Milestones :: Perspectives :: Research
HIV, TB, Malaria
WHO and Global Fund Sign Cooperation Agreement to Scale Up HIV, TB and Malaria Interventions and Strengthen Health Systems
30 June 2021 News release
The World Health Organization and the Global Fund to Fight AIDS, Tuberculosis and Malaria signed a cooperation and financing agreement to implement 10 strategic initiatives to accelerate the end of AIDS, tuberculosis and malaria as epidemics and strengthen systems for health.
This new agreement, which will cover the 2021-2023 implementation period, aims to address some of the persistent challenges that impede progress against the three diseases and protect hard-won gains from new pandemics like COVID-19.
In 2019, a total of 1.4 million people died from tuberculosis and an estimated 409,000 people died from malaria. In 2020, 690,000 people died from AIDS-related illnesses.
Through the new agreement, the strategic initiatives seek to:
Expand TB preventive treatment for people living with HIV in 9 countries across Africa;
Strengthen efforts to provide differentiated HIV service delivery;
Accelerate efforts to find people with TB missed by health systems in 20 countries;
Accelerate introduction of innovation for multi-drug resistant TB treatment through regional operational research in Eastern and Central Europe;
Support 26 countries and territories to eliminate malaria by 2025;
Improve country data collection and use to develop evidence-informed policy;
Foster the rapid uptake of service delivery innovations with South to South Learning;
Improve quality of care;
Encourage rapid uptake of procurement and supply chain management innovation; and
Increase program sustainability, facilitate the transition to domestic financing and improve program efficiency.
WHO and the Global Fund have a long and successful partnership working together to scale up HIV, TB and malaria interventions and strengthen health systems in many countries. Through focused efforts and catalytic investments, this collaboration has contributed to significantly reduce the disease burdens of HIV, TB and malaria worldwide, saving millions of lives since 2002…